Chlormezanone in the treatment of migraine attacks: a double blind comparison with diazepam and placebo.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 6760981)

Published in Cephalalgia on December 01, 1982

Authors

P Tfelt-Hansen, K Jensen, P Vendsborg, M Lauritzen, J Olesen

Articles by these authors

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85

The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40

New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97

Understanding the biologic basis of migraine. N Engl J Med (1994) 5.25

An atomic-resolution nanomechanical mass sensor. Nat Nanotechnol (2008) 4.92

Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol (1991) 4.78

Autoregulation of brain circulation in severe arterial hypertension. Br Med J (1973) 4.11

Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86

Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) (1988) 2.84

A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84

Genetic analysis using genomic representations. Proc Natl Acad Sci U S A (1998) 2.52

CGRP may play a causative role in migraine. Cephalalgia (2002) 2.40

Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J (2000) 2.38

Questionnaire versus clinical interview in the diagnosis of headache. Headache (1991) 2.36

Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia (1992) 2.33

Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol (1988) 2.30

Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia (1996) 2.29

Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology (2006) 2.24

The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem (1999) 2.21

Denitrification, dissimilatory reduction of nitrate to ammonium, and nitrification in a bioturbated estuarine sediment as measured with N and microsensor techniques. Appl Environ Microbiol (1992) 2.12

Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health (1992) 2.12

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet (1991) 2.11

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10

Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol (1981) 2.03

Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia (2006) 2.01

Modification of activity-dependent increases of cerebral blood flow by excitatory synaptic activity and spikes in rat cerebellar cortex. J Physiol (1998) 2.00

Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors. J Cell Biol (1999) 2.00

Symptomatic and nonsymptomatic headaches in a general population. Neurology (1992) 1.99

The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97

Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol (1995) 1.96

Increased familial risk and evidence of genetic factor in migraine. BMJ (1995) 1.96

A nosographic analysis of the migraine aura in a general population. Brain (1996) 1.91

Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83

Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia (1995) 1.82

Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81

Coupling and uncoupling of activity-dependent increases of neuronal activity and blood flow in rat somatosensory cortex. J Physiol (2001) 1.81

Evidence for two structural genes for alkaline phosphatase in Bacillus subtilis. J Bacteriol (1990) 1.79

Ultrasound-guided bilateral dual transversus abdominis plane block: a new four-point approach. Acta Anaesthesiol Scand (2011) 1.78

An antigen common to a wide range of bacteria. I. The isolation of a 'common antigen' from Pseudomonas aeruginosa. Acta Pathol Microbiol Scand B (1980) 1.75

Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia (1994) 1.68

Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology (2010) 1.66

Pressure-controlled palpation: a new technique which increases the reliability of manual palpation. Cephalalgia (1995) 1.64

Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect (1995) 1.63

Gamma-hydroxybutyrate--a drug of abuse. Acta Neurol Scand (2006) 1.63

Antibiotic susceptibility and phage-type pattern of Staphylococcus aureus strains isolated from patients in general practice compared to strains from hospitalized patients. Scand J Infect Dis (1990) 1.63

Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62

Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology (1998) 1.62

Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports (2001) 1.60

Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology (1994) 1.59

Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59

Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum (1997) 1.58

Attempted suicide, depression and physical diseases: a 1-year follow-up study. Psychother Psychosom (1994) 1.58

Neurosurgery for trigeminal neuralgia: comparison of alcohol block, neurectomy, and radiofrequency coagulation. Clin J Pain (1996) 1.58

Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57

Prophylactic Swallowing Exercises in Head and Neck Cancer Radiotherapy. Dysphagia (2015) 1.55

Combined treatment with antibacterial chemotherapeutical agents in staphylococcal infections. Q J Med (1969) 1.54

Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues. Pain (1994) 1.54

Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J Biol Chem (1995) 1.54

Interrelations between migraine and tension-type headache in the general population. Arch Neurol (1992) 1.53

Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 1.52

Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem (1996) 1.50

Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol (2003) 1.49

The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem (2000) 1.49

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.47

Diagnosis and management of migraine. BMJ (1996) 1.47

Botulinum toxin in headache treatment: the end of the road? Cephalalgia (2006) 1.46

The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology (1972) 1.46

An antigen common to a wide range of bacteria. 2. A biochemical study of a "common antigen" from Pseudomonas aeruginosa. Acta Pathol Microbiol Scand B (1980) 1.45

Nuclear dots: actors on many stages. Immunobiology (1997) 1.45

Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45

Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab (1998) 1.44

Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia (1994) 1.44

Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain (1999) 1.43

Transient impairments in single muscle fibre contractile function after prolonged cycling in elite endurance athletes. Acta Physiol (Oxf) (2013) 1.42

Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol (1990) 1.41

[Visual fields defects following treatment with vigabatrin]. Ugeskr Laeger (1999) 1.41

The effect of metoprolol upon blood pressure, cerebral blood flow and oxygen consumption in patients subjected to craniotomy for cerebral tumours. Acta Anaesthesiol Scand (1994) 1.40

The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia (2005) 1.39

The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry (2004) 1.39

Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state. Cephalalgia (1996) 1.39

Multiple sclerosis: results of screening by the Token test in a representative sample. Ital J Neurol Sci (1992) 1.39

Evaluation of pericranial myofascial nociception by pressure algometry. Reproducibility and factors of variation. Cephalalgia (1992) 1.39

[Babesiosis]. Ugeskr Laeger (1998) 1.39

Ring chromosome 18 in mother and daughter. J Ment Defic Res (1970) 1.39

Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J Physiol (2007) 1.38

[Are psychiatric diseases brain diseases?]. Ugeskr Laeger (1999) 1.38

[Sumatriptan (Imigran) to patients with hemiplegic migraine?]. Ugeskr Laeger (1992) 1.38

[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38

Pressure-sensitive devices. Pain (1995) 1.38

[Assertive community treatment of psychoses]. Ugeskr Laeger (2000) 1.38

Reliability of histo-pathological diagnosis of squamous epithelial changes of the uterine cervix. Acta Pathol Microbiol Scand A (1978) 1.38

The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37

Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol (1983) 1.36

Resource allocation to brain research in Europe (RABRE). Eur J Neurosci (2006) 1.34

A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain (2002) 1.34

Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol (1999) 1.33

A Bacillus subtilis secreted phosphodiesterase/alkaline phosphatase is the product of a Pho regulon gene, phoD. Microbiology (1996) 1.33